Business & Securities Lawsuit

CellCyte Genetics Faces lawsuit claims

Details: Parent Category: Lawsuit News Alerts; Category: Securities Fraud And Business Lawsuit Information

CellCyte Genetics said it will "defend itself vigorously" against three shareholder lawsuits filed this week, and announced it has hired Philadelphia-based law firm Duane Morris.

The suits allege executives and outside shareholders of the small biotechnology company artificially inflated its stock price and defrauded investors by making misleading claims.

"We look forward to meeting these legal claims in court," said CEO Gary Reys.

ZymoGenetics

Stock drops after product approval

ZymoGenetics stock fell 16.6 percent Friday, the most in 5-<133>1/2 years, a day after the company won approval of its first product, a drug to control bleeding in surgery patients.

The approval didn't keep Kevin Degeeter at Oppenheimer & Co. from downgrading the stock. Degeeter is "concerned about product pricing and market acceptance" of Recothrom, he said in a note to clients. ZymoGenetics says the product will cost 20 percent more than a standard drug derived from cow's blood.

"We believe ZymoGenetics could trade down to $5-$6 on a soft launch for Recothrom," Degeeter said in the note. ZymoGenetics closed down $2.16 at $10.89 Friday.

Seattle Genetics

Company to sell shares; stock falls

Seattle Genetics stock declined 6.5 percent Friday after the company announced plans to sell 10 million common shares at $9 each.

The Bothell developer of targeted drugs for cancer expects to raise $84.8 million and use the proceeds to fund research and development, including clinical trials.

Seattle Genetics stock fell 63 cents to $9.07 Friday; the stock has declined 20 percent this year.

< Prev

Free Case Review

Your Name:(*)

Please check your name for errors.
E-mail Address:(*)

Please provide your valid email address
Phone Number:

Invalid Input
Street Address:

Invalid Input
City:

Invalid Input
State, Select Your State From The List:

Invalid Input
Zip Code:(*)

Invalid Zip Code. Please enter your US Zip code.
Method you prefer we use to contact you?

Invalid Input
General Case Information Please briefly explain your situation:(*)

Please let us know your message.
By submitting this inquiry I agree that the information that I will receive in response to the above question is general information and I will not be charged for the response to this e-mail question. I also agree that the above does not constitute a request for legal advice and that I am not forming an attorney client relationship by submitting this question. I understand that I may only retain an attorney by entering into an agreement, and that I am not hereby entering into an agreement by submitting my question.